NASDAQ:BIOC - Biocept Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.58 -0.22 (-12.22 %)
(As of 11/14/2018 04:00 PM ET)
Previous Close$1.80
Today's Range$1.46 - $1.69
52-Week Range$1.73 - $36.00
Volume63,053 shs
Average Volume266,810 shs
Market Capitalization$4.12 million
P/E Ratio-0.07
Dividend YieldN/A
Beta1.82

Analyst Ratings

Biocept (NASDAQ:BIOC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.25, suggesting that the stock has a possible downside of 20.89%. The high price target for BIOC is $1.50 and the low price target for BIOC is $1.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.503.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.25$1.25$1.25$1.25
Price Target Upside: 20.89% downside50.20% downside594.44% upside420.83% upside

Biocept (NASDAQ:BIOC) Consensus Price Target History

Price Target History for Biocept (NASDAQ:BIOC)

Biocept (NASDAQ:BIOC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/3/2018Dawson JamesReiterated RatingBuyHighView Rating Details
5/23/2018Westpark CapitalDowngradeOutperform ➝ HoldLowView Rating Details
11/14/2017Chardan CapitalReiterated RatingBuy ➝ Buy$2.50 ➝ $1.50N/AView Rating Details
3/13/2017Roth CapitalReiterated RatingBuy$1.60 ➝ $3.00LowView Rating Details
(Data available from 11/14/2016 forward)
This page was last updated on 11/14/2018 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel